These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 6242692)

  • 1. [Monitoring of at-risk pregnancies through E3 and HPL].
    Bieglmayer C; Spona J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6242692
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma hormone assay in pregnancy.
    Branconi F; Cariati E; Cappelli G; Paladini S; Scarselli G
    Int J Biol Res Pregnancy; 1981; 2(3):146-8. PubMed ID: 6174457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical indications for the purposeful monitoring of at-risk pregnancies using radioimmunological HPL determinations].
    Herter U; Alexander H; Radzuweit H
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():50-6. PubMed ID: 6242694
    [No Abstract]   [Full Text] [Related]  

  • 4. [Monitoring of HPL, estriol and estetrol in high-risk pregnancy].
    Gherzi R; Pastore M; Labate D
    Minerva Ginecol; 1981 Oct; 33(10):911-6. PubMed ID: 7312213
    [No Abstract]   [Full Text] [Related]  

  • 5. [The determination of human placental lactogen (HPL) for hormonal supervision in late pregnancy].
    Nieder J; Kapitza W
    Zentralbl Gynakol; 1976; 98(18):1129-36. PubMed ID: 983489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human placental lactogen.
    Letchworth AT
    Contrib Gynecol Obstet; 1976; 2():114-42. PubMed ID: 802077
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of the determination of free estriol (E3) and of placental lactogen (HPL) in the monitoring of high-risk pregnancy].
    Ghionni A; Briani G; Pasini L
    Minerva Ginecol; 1979; 31(1-2):13-8. PubMed ID: 471308
    [No Abstract]   [Full Text] [Related]  

  • 8. [The monitoring of risk pregnancies by E3 and HPL].
    Bieglmayer C; Spona J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():38-42. PubMed ID: 6211052
    [No Abstract]   [Full Text] [Related]  

  • 9. [Relation of placental prolactogen and E3 in the blood of pregnant women to placental grading by ultrasonography and its clinical significance].
    Wang SQ
    Zhonghua Fu Chan Ke Za Zhi; 1989 Jul; 24(4):220-3, 252-3. PubMed ID: 2695301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation and correlation of hormone levels in normal and pathologic pregnancies.
    Bartl W; Riss P; Bieglmayer C; Gring H
    Biol Res Pregnancy Perinatol; 1984; 5(4):143-8. PubMed ID: 6525387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Human placentar lactogen (HPL) in the serum of pregnant women with diabetes, Rh-incompatibility, severe toxemia and twins].
    Bellmann O; Lang N
    Z Geburtshilfe Perinatol; 1973 Apr; 177(2):110-8. PubMed ID: 4198068
    [No Abstract]   [Full Text] [Related]  

  • 12. Maternal serum HPL levels in normal and complicated pregnancy as an index of placental function.
    Ylikorkala O
    Acta Obstet Gynecol Scand Suppl; 1973; 26():1-52. PubMed ID: 4522254
    [No Abstract]   [Full Text] [Related]  

  • 13. Placental alkaline phosphatase compared with human placental lactogen and oestriol in high-risk pregnancies.
    Ronin-Walknowska E; Holmgren PA; von Schoultz B; Stigbrand T
    Gynecol Obstet Invest; 1984; 18(4):206-11. PubMed ID: 6510780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The laboratory in monitoring high-risk pregnancy].
    Radillo L; Cociancich G; D'Atri A; Ghionni A; Mangiarotti M
    Quad Sclavo Diagn; 1981 Jun; 17(2):164-71. PubMed ID: 6973774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High risk pregnancies. Prognostic value and plasma levels of human chorionic somatomammotropin].
    Cohen M; Dumont M; Bertrand J
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(7):697-713. PubMed ID: 4196593
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential determination of serum human placental lactogen, estriol, and estetrol for assessment of fetal morbidity.
    Kundu N; Carmody PJ; Didolkar SM; Petersen LP
    Obstet Gynecol; 1978 Nov; 52(5):513-20. PubMed ID: 724167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of levels of chorionic somatomommotropic hormone during high risk pregnancies].
    Gaspard U; Franchimont P
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):324-7. PubMed ID: 4681535
    [No Abstract]   [Full Text] [Related]  

  • 18. [Estriol and human placental lactogen as risk indicators in pregnancies of diabetic and hypertensive patients].
    Günter HH; Berger L; Messner U; Niesert S
    Z Geburtshilfe Neonatol; 1995; 199(4):142-7. PubMed ID: 7497015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monitoring of EPH-gestosis through the Gestosis Index and hormone determinations].
    Weber H
    Fortschr Med; 1977 Jul; 95(25):1630-34. PubMed ID: 69597
    [No Abstract]   [Full Text] [Related]  

  • 20. [Monitoring of pregnancies by hormone assays, the value of HPL estimations (author's transl)].
    Gitsch E; Janisch H; Spona J
    Wien Klin Wochenschr; 1973 Sep; 85(36):585-8. PubMed ID: 4750614
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.